128 related articles for article (PubMed ID: 27994680)
1. Association between the
Ning L; Rao W; Yu Y; Liu X; Pan Y; Ma Y; Liu R; Zhang S; Sun H; Yu Q
J Cancer; 2016; 7(15):2420-2426. PubMed ID: 27994680
[TBL] [Abstract][Full Text] [Related]
2. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
[TBL] [Abstract][Full Text] [Related]
3. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
4. Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population.
Liu R; Ning L; Liu X; Zhang H; Yu Y; Zhang S; Rao W; Shi J; Sun H; Yu Q
Oncotarget; 2017 Feb; 8(9):15838-15845. PubMed ID: 28178662
[TBL] [Abstract][Full Text] [Related]
5. Association of the ATM gene polymorphisms with papillary thyroid cancer.
Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
[TBL] [Abstract][Full Text] [Related]
6. AXIN2 is Associated With Papillary Thyroid Carcinoma.
Liu X; Li S; Lin X; Yan K; Zhao L; Yu Q; Liu X
Iran Red Crescent Med J; 2016 Feb; 18(2):e20960. PubMed ID: 27168945
[TBL] [Abstract][Full Text] [Related]
7. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
8. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
9. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
[TBL] [Abstract][Full Text] [Related]
10. Association of rs712 polymorphism in a let-7 microRNA-binding site of
Gallegos-Arreola MP; Zúñiga-González GM; Gómez-Mariscal K; Rosales-Reynoso MA; Luis L; Puebla-Pérez AM; Pineda-Razo T
Iran J Basic Med Sci; 2019 Mar; 22(3):324-327. PubMed ID: 31156795
[TBL] [Abstract][Full Text] [Related]
11. Association of rs944289, rs965513, and rs1443434 in TITF1/TITF2 with Risks of Papillary Thyroid Carcinoma and with Nodular Goiter in Northern Chinese Han Populations.
Zhang X; Gu Y; Li Y; Cui H; Liu X; Sun H; Yu Q; Yu Y; Liu Y; Zhan S; Cheng Y
Int J Endocrinol; 2020; 2020():4539747. PubMed ID: 32104174
[TBL] [Abstract][Full Text] [Related]
12. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
[TBL] [Abstract][Full Text] [Related]
14. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
16. [Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):390-5. PubMed ID: 18683134
[TBL] [Abstract][Full Text] [Related]
17. Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer.
Zhang X; Gu Y; Liu X; Yu Y; Shi J; Yu Q; Sun H; Kanu JS; Zhan S; Liu Y
Int J Endocrinol; 2015; 2015():802562. PubMed ID: 26664358
[TBL] [Abstract][Full Text] [Related]
18. Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population.
Jin M; Lu F; Li X; Zhou W; Li S; Jiang Y; Wu H; Wang J
J Clin Lab Anal; 2023 Jan; 37(1):e24806. PubMed ID: 36510353
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma].
Pei D; Xue G; Wu JF; Wang DM; Qin XJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
